Literature DB >> 26162957

Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future.

Azfar Sheikh1, Nileshkumar J Patel2, Nikhil Nalluri3, Kanishk Agnihotri4, Jonathan Spagnola3, Aashay Patel5, Deepak Asti3, Ritesh Kanotra3, Hafiz Khan3, Chirag Savani6, Shilpkumar Arora7, Nilay Patel4, Badal Thakkar8, Neil Patel9, Dhaval Pau3, Apurva O Badheka10, Abhishek Deshmukh11, Marcin Kowalski3, Juan Viles-Gonzalez12, Hakan Paydak13.   

Abstract

Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide and the most common arrhythmia leading to hospitalization. Due to a substantial increase in incidence and prevalence of AF over the past few decades, it attributes to an extensive economic and public health burden. The increasing number of hospitalizations, aging population, anticoagulation management, and increasing trend for disposition to a skilled facility are drivers of the increasing cost associated with AF. There has been significant progress in AF management with the release of new oral anticoagulants, use of left atrial catheter ablation, and novel techniques for left atrial appendage closure. In this article, we aim to review the trends in epidemiology, hospitalization, and cost of AF along with its future implications on public health. Published by Elsevier Inc.

Entities:  

Keywords:  Atrial fibrillation; Cost analysis; Epidemiology; Future implications; Trends in hospitalization

Mesh:

Year:  2015        PMID: 26162957     DOI: 10.1016/j.pcad.2015.07.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  17 in total

Review 1.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Phyo H Khaing; Deirdre A Lane
Journal:  Cochrane Database Syst Rev       Date:  2017-04-05

Review 2.  Management of cardiovascular diseases in patients with obesity.

Authors:  Carl J Lavie; Ross Arena; Martin A Alpert; Richard V Milani; Hector O Ventura
Journal:  Nat Rev Cardiol       Date:  2017-07-27       Impact factor: 32.419

Review 3.  Atrial fibrillation ablation strategies and technologies: past, present, and future.

Authors:  Thomas J Buist; Douglas P Zipes; Arif Elvan
Journal:  Clin Res Cardiol       Date:  2020-10-22       Impact factor: 5.460

4.  Declining Rates of Hospitalization for Selected Cardiovascular Disease Conditions Among Adults Aged ≥35 Years With Diagnosed Diabetes, U.S., 1998-2014.

Authors:  Nilka Ríos Burrows; YanFeng Li; Edward W Gregg; Linda S Geiss
Journal:  Diabetes Care       Date:  2017-11-17       Impact factor: 19.112

Review 5.  Evaluating the benefits of home-based management of atrial fibrillation: current perspectives.

Authors:  Azfar B Sheikh; Jamie R Felzer; Abdullah Bin Munir; Daniel P Morin; Carl J Lavie
Journal:  Pragmat Obs Res       Date:  2016-10-13

Review 6.  Biatrial versus Isolated Left Atrial Ablation in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Hongmu Li; Xifeng Lin; Xun Ma; Jun Tao; Rongjun Zou; Songran Yang; Haibo Liu; Ping Hua
Journal:  Biomed Res Int       Date:  2018-04-29       Impact factor: 3.411

7.  Divergent Temporal Trends in Morbidity and Mortality Related to Heart Failure and Atrial Fibrillation: Age, Sex, Race, and Geographic Differences in the United States, 1991-2015.

Authors:  Ramachandran S Vasan; Yi Zuo; Bindu Kalesan
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

8.  Clinical Pharmacology-Driven Translational Research to Optimize Bedside Therapeutics of Sotalol Therapy.

Authors:  Elyes Dahmane; Kathy Tang; Jogarao V S Gobburu; T Joseph Mattingly; Brent N Reed; Vincent Y See; Joshuha Ayres; Vijay Ivaturi
Journal:  Clin Transl Sci       Date:  2019-08-12       Impact factor: 4.689

9.  Shortened leukocyte telomere length as a potential biomarker for predicting the progression of atrial fibrillation from paroxysm to persistence in the short-term.

Authors:  Siyu Wang; Yuanfeng Gao; Lei Zhao; Roumu Hu; Xinchun Yang; Ye Liu
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

10.  Hospital and clinical care costs associated with atrial fibrillation for Medicare beneficiaries in the Cardiovascular Health Study and the Framingham Heart Study.

Authors:  Joseph Ac Delaney; Xiaoyan Yin; João Daniel Fontes; Erin R Wallace; Asheley Skinner; Na Wang; Bradley G Hammill; Emelia J Benjamin; Lesley H Curtis; Susan R Heckbert
Journal:  SAGE Open Med       Date:  2018-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.